Zegami Revenue and Competitors
Estimated Revenue & Valuation
- Zegami's estimated annual revenue is currently $70k per year.
- Zegami's estimated revenue per employee is $70,000
Employee Data
- Zegami has 1 Employees.
- Zegami grew their employee count by 0% last year.
Zegami's People
Name | Title | Email/Phone |
---|---|---|
1 | Software Engineer | Reveal Email/Phone |
Zegami Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $12.6M | 90 | -36% | $14.1M | N/A |
#2 | $83.2M | 468 | -3% | $251M | N/A |
#3 | $14M | 100 | 1% | N/A | N/A |
#4 | $14.6M | 0 | N/A | $12.5M | N/A |
#5 | $30.3M | 197 | -6% | N/A | N/A |
#6 | $0.1M | 6 | -25% | $2.6M | N/A |
#7 | $45.1M | 293 | 2% | N/A | N/A |
#8 | $4.8M | 43 | -7% | N/A | N/A |
#9 | $399.3M | 2037 | 40% | N/A | N/A |
#10 | $44M | 286 | 4% | N/A | N/A |
What Is Zegami?
Zegami was born out of a collaboration led by Oxford scientist Steve Taylor and tech polymath Roger Noble to analyse and understand large datasets from experiments generating thousands of images of cancer cells and data from the human genome. The application of Zegami starts with any output from any imaging methods e.g microscopes, ultrasound, X-Rays allowing scientists or clinicians to look for trends and outliers in large data sets. Building on this Zegami works with teams creating machine learning models where it is key to understand and look for problems or biases in the training data. Zegami allows rapid visualisation of how related the images are and what features in the image the model is focusing on.
keywords:N/AN/A
Total Funding
1
Number of Employees
$70k
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Zegami News
... Scope And Outlook | Canon Medical, VARIAN, MOSAIQ Radiation Oncology, Insignia Medical Systems, Ambra Health, Zegami, Intelligent Medical Software.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | N/A | 2 | -50% | N/A |
#2 | $0.2M | 2 | -85% | N/A |
#3 | $0.1M | 2 | -33% | N/A |
#4 | $0.2M | 3 | -40% | N/A |
#5 | $0.2M | 3 | -25% | N/A |